OTCMKTS:CURR

Cure Pharmaceutical Holding Stock Insider Trading

etoro logo Buy CURR
*Your capital is at risk
$3.11
-0.170 (-5.18%)
At Close: Jun 03, 2026

CURE Pharmaceutical Holding Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 14.96M and sold 0 CURR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 14.96M shares
Sell 0 shares
100% Buy Activity
Weak Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Aug 16, 2022
Buy
Common Stock
Costantino Robert J
Director
Director 0
Value: $0
Aug 12, 2022
Buy
Common Stock
A-Award
Costantino Robert J
Director
Director 226 764
Value: $0
Aug 12, 2022
Buy
Common Stock
A-Award
Costantino Robert J
Director
Director 226 764
Value: $0
Jul 25, 2022
Buy
Common Stock
A-Award
Bagg Gerald
Director
Director 220 795
Value: $0
Jul 25, 2022
Buy
Common Stock
A-Award
Bagg Gerald
Director
Director 220 795
Value: $0
Jul 25, 2022
Buy
Common Stock
A-Award
Davidson Robert Steven
Director
Director 220 795
Value: $0
Jul 25, 2022
Buy
Common Stock
A-Award
Davidson Robert Steven
Director
Director 220 795
Value: $0
Jul 22, 2022
Buy
Common Stock
J-Other
Bagg Gerald
Insider
Other 0
Value: $0
Jul 22, 2022
Buy
Common Stock
J-Other
Bagg Gerald
Insider
Other 0
Value: $0
Jul 22, 2022
Buy
Common Stock
J-Other
Bennett Joel M
Insider
Other 0
Value: $0
Jul 22, 2022
Buy
Stock Option
A-Award
Bennett Joel M
CFO,cao, Treasurer & Secretary
C-Suite Officer 200 000
Value: $0
Jul 22, 2022
Buy
Common Stock
A-Award
Davidson Robert Steven
Director 500 000
Value: $0
Jul 22, 2022
Buy
Common Stock
A-Award
Davidson Robert Steven
Director 500 000
Value: $0
Jul 22, 2022
Buy
Stock Option
A-Award
Bennett Joel M
CFO,cao, Treasurer & Secretary
C-Suite Officer 200 000
Value: $0
Jul 22, 2022
Buy
Common Stock
J-Other
Bennett Joel M
Insider
Other 0
Value: $0
Sep 23, 2021
Buy
Restricted Stock Unit
A-Award
Salkind Gene Z
Director
Director 117 647
Value: $82.4K
Sep 23, 2021
Buy
Restricted Stock Unit
A-Award
Salkind Gene Z
Director
Director 117 647
Value: $82.4K
May 27, 2021
Buy
Common Stock
P-Purchase
Berlent Jonathan
Chief Business Officer
Officer 10 000
Value: $7K
May 27, 2021
Buy
Common Stock
P-Purchase
Berlent Jonathan
Chief Business Officer
Officer 10 000
Value: $7K
Oct 23, 2020
Buy
Stock Option
A-Award
Berlent Jonathan
Chief Business Officer
Officer 187 500
Value: $225.0K
Oct 23, 2020
Buy
Stock Option
A-Award
Berlent Jonathan
Chief Business Officer
Officer 62 500
Value: $75.0K
Oct 23, 2020
Buy
Stock Option
A-Award
Berlent Jonathan
Chief Business Officer
Officer 62 500
Value: $75.0K
Oct 23, 2020
Buy
Stock Option
A-Award
Berlent Jonathan
Chief Business Officer
Officer 187 500
Value: $225.0K
Sep 23, 2020
Buy
Restricted Stock Unit
A-Award
Goldin Anna
Director
Director 61 654
Value: $0
Sep 23, 2020
Buy
Restricted Stock Unit
A-Award
Bell John K
Director
Director 61 654
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CURE PHARMACEUTICAL HOLDING CORP.
CURE Pharmaceutical Holding
CURE Pharmaceutical Holding Corp., a biopharmaceutical company, focuses on the development and manufacturing of drug formulation and drug delivery technologies to enhance drug safety, efficacy, and patient adherence. It operates through two segments, Cure and Sera Labs. The company's pharmaceutical drug programs include CUREfilm Blue, a sildenafil oral thin film (OTF) for the treatment of erectile dysfunction; CUREfilm Canna, a cannabinoid produc...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE